Skip to content

Study · Randomized controlled trial · n = 27 · 2018

2 results

To mirror or not to mirror upon mutual gaze, oxytocin can pave the way: A cross-over randomized placebo-controlled trial.

Prinsen J, Brams S, Alaerts K

Psychoneuroendocrinology22 Feb 2018Cited by 14 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In healthy men, a single dose of intranasal oxytocin did not uniformly enhance motor resonance upon direct gaze.

    In plain wordsIn healthy men, one dose of oxytocin nasal spray did not boost mirroring of others' movements for everyone.

    Peptide
    Oxytocin
    Outcome
    No significant changeMotor resonance upon direct versus averted gaze
    Study

    n = 27

    Comparator
    Placebo
    Outcome group
    Social behavior and cognition · Nervous system and cognition
    Studied dose
    24 IU · intranasal · single doseAs given in this study (human).

    Source sentences

    Summary
    a single dose of OXT did not uniformly enhance this effect.
    1 context sentence
    Summary · context
    The study involved a double-blind, placebo-controlled, cross-over trial with twenty-seven healthy adult men (19-32 y).
  2. 02HumanRandomized controlled trialEfficacy outcome

    In healthy men with high self-reported attachment avoidance, intranasal oxytocin showed a stronger enhancement of motor resonance upon direct eye contact than in men with low attachment avoidance.

    In plain wordsIn healthy men who avoid close attachment, oxytocin nasal spray increased mirroring of others' movements during eye contact more than in men with low avoidance.

    Peptide
    Oxytocin
    Outcome
    IncreaseMotor resonance upon direct eye contact in men with high attachment avoidance
    Study

    n: not reported in source

    Comparator
    Placebo
    Outcome group
    Social behavior and cognition · Nervous system and cognition
    Studied dose
    24 IU · intranasal · single doseAs given in this study (human).

    Source sentences

    Summary
    Significant moderations of the treatment effect were noted however, indicating that participants with high self-reports of attachment avoidance displayed a stronger OXT-treatment effect (enhancement of motor resonance upon direct eye contact), compared to participants with low attachment avoidance.
    2 context sentences
    Summary · context
    Particularly, while participants with high attachment avoidance initially displayed a reduced propensity to increase their motor resonance upon direct eye contact, a single dose of OXT was able to promote an otherwise avoidant individual's propensity to engage in motor resonance upon a salient socia…
    Summary · context
    The study involved a double-blind, placebo-controlled, cross-over trial with twenty-seven healthy adult men (19-32 y).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Registered trials1

Trials this study reports on, or that list this study as a reference. Registry data from ClinicalTrials.gov.

1 trial · 1 completed · source ClinicalTrials.gov (opens in a new tab)

CompletedPhase 3NCT03640156

Modulating Socially Adaptive Mirror System Functioning in Autism by Oxytocin

KU Leuvenn = 2526 Jul 2018 to 19 Dec 2019

Autism Spectrum Disorder

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 01:30 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:49 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.